Alisertib Sodium NEW
| Price | $238 | $357 | $536 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Alisertib Sodium | CAS No.: 1028486-06-7 |
| Purity: 99.77% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Alisertib Sodium |
| Description | Alisertib Sodium (MLN 8237 Sodium)is a selective Aurora A inhibitor that causes G2/M phase arrest and chromosomal misalignment, leading to tumour cell apoptosis, and can also inhibit STAT3 Tyr705 phosphorylation, resulting in downregulation of c-Myc expression. |
| In vitro | Methods: The anti-proliferative activity of Alisertib Sodium (MLN 8237 Sodium) was evaluated in various tumor cell lines. Cells were treated with the compound in vitro, and cell proliferation was measured to determine IC?? values. Results: Alisertib Sodium exhibited significant anti-proliferative effects across different tumor cell lines, with IC?? values ranging from 15 to 469 nM, indicating cell line-dependent sensitivity differences [4]. |
| In vivo | Methods: To investigate the inhibitory effect of Alisertib Sodium (MLN 8237 Sodium) on colorectal tumor growth, a HCT-116 colon cancer xenograft model was established in nude mice. Mice were administered Alisertib orally at doses of 3, 10, or 30 mg/kg once daily for 3 consecutive weeks. Results: Alisertib Sodium significantly inhibited tumor growth in a dose-dependent manner. The tumor growth inhibition (TGI) rates for the 3, 10, and 30 mg/kg groups were 43.3%, 84.2%, and 94.7%, respectively [4]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Alisertib sodium |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Urea | Tamoxifen | Guanidine hydrochloride | Hydroxychloroquine | Metronidazole | Formamide | Paeonol | Naringin | Alginic acid |
| Related Compound Libraries | Bioactive Compound Library | Epigenetics Compound Library | Kinase Inhibitor Library | JAK-STAT Compound Library | Post-Translational Modification Compound Library | Stem Cell Differentiation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Transcription Factor-Targeted Compound Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $50.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-22 | |
|
Wuhan Nutra Biotechnology Co.,Ltd
|
2024-11-01 | |||
| $350.00 |
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY